Ken Griffin Danaher Corp Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Danaher Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 786,600 shares of DHR stock, worth $191 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

786,600

Previous 542,400 45.02%

Holding current value

$191 Million

Previous $135 Million 45.1%

% of portfolio

0.04%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $5.84 Million - $6.65 Million	-24,808 Reduced 95.29%	1,226 $306,000
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $10.6 Million - $12.1 Million	-47,305 Reduced 64.5%	26,034 $6.5 Million
Q4 2023 Feb 14, 2024	SELL	$185.1 - $233.13 $240 Million - $302 Million	-1,297,500 Reduced 94.65%	73,339 $17 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $181 Million - $206 Million	775,503 Added 130.26%	1,370,839 $340 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $9.66 Million - $11 Million	42,940 Added 7.77%	595,336 $143 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $61.2 Million - $70.7 Million	255,111 Added 85.81%	552,396 $139 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $87.9 Million - $103 Million	-364,069 Reduced 55.05%	297,285 $78.9 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $142 Million - $865 Million	573,907 Added 656.29%	661,354 $171 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $227 Million - $287 Million	-958,741 Reduced 91.64%	87,447 $22.2 Million
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $67.8 Million - $83.2 Million	-263,547 Reduced 20.12%	1,046,188 $307 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $92.1 Million - $104 Million	315,277 Added 31.7%	1,309,735 $431 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $96.7 Million - $118 Million	355,375 Added 55.61%	994,458 $303 Million
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $208 Million - $251 Million	-923,609 Reduced 59.1%	639,083 $172 Million
Q1 2021 May 17, 2021	BUY	$212.38 - $245.9 $47.1 Million - $54.5 Million	221,808 Added 16.54%	1,562,692 $352 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $79 Million - $91.3 Million	371,927 Added 38.38%	1,340,884 $298 Million
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $66 Million - $80.2 Million	-372,649 Reduced 27.78%	968,957 $209 Million
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $82.7 Million - $114 Million	-642,647 Reduced 32.39%	1,341,606 $237 Million
Q1 2020 May 15, 2020	BUY	$121.39 - $169.05 $237 Million - $330 Million	1,954,168 Added 6495.49%	1,984,253 $275 Million
Q4 2019 Feb 14, 2020	BUY	$133.47 - $153.48 $3.12 Million - $3.59 Million	23,359 Added 347.29%	30,085 $4.62 Million
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $388,733 - $420,515	2,871 Added 74.47%	6,726 $971,000
Q2 2019 Aug 14, 2019	SELL	$124.88 - $143.73 $42.5 Million - $49 Million	-340,671 Reduced 98.88%	3,855 $551,000
Q1 2019 May 15, 2019	SELL	$97.62 - $132.29 $47 Million - $63.7 Million	-481,441 Reduced 58.29%	344,526 $0
Q4 2018 Feb 14, 2019	BUY	$94.85 - $109.54 $72.6 Million - $83.9 Million	765,694 Added 1270.38%	825,967 $85.2 Million
Q3 2018 Nov 13, 2018	SELL	$98.13 - $108.9 $30.2 Million - $33.5 Million	-307,626 Reduced 83.62%	60,273 $0
Q2 2018 Aug 10, 2018	SELL	$96.1 - $103.24 $108 Million - $116 Million	-1,123,820 Reduced 75.34%	367,899 $0
Q1 2018 May 11, 2018	BUY	$92.16 - $103.8 $105 Million - $119 Million	1,142,467 Added 327.12%	1,491,719 $146 Million
Q4 2017 Feb 09, 2018	SELL	$85.26 - $94.62 $154 Million - $171 Million	-1,805,669 Reduced 83.79%	349,252 $32.4 Million
Q3 2017 Nov 09, 2017	BUY	$79.29 - $88.45 $171 Million - $191 Million	2,154,921	2,154,921 $185 Million

Others Institutions Holding DHR

# of Institutions

2,432

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.11M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account